Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study
Sandro Loche,1 Shankar Kanumakala,2 Philippe Backeljauw,3 Karl Otfried Schwab,4 Alfonso M Lechuga-Sancho,5- 7 Altaher Esmael,8 Dragan Urosevic,9 Anca Boldea,8 Markus Zabransky8 1Endocrinologia Pediatra e Centro, Screening Neonatale, Ospedale Pediatrico Microcitemico "A. Cao", Cagliari, Ita...
Saved in:
Main Authors: | Loche S (Author), Kanumakala S (Author), Backeljauw P (Author), Schwab KO (Author), Lechuga-Sancho AM (Author), Esmael A (Author), Urosevic D (Author), Boldea A (Author), Zabransky M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Growth hormone treatment in non-growth hormone-deficient children
by: Sandro Loche, et al.
Published: (2014) -
Ten years of biosimilar recombinant human growth hormone in Europe
by: Saenger P
Published: (2017) -
Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
by: Hou L, et al.
Published: (2015) -
Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
by: Borrás Pérez MV, et al.
Published: (2017) -
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data
by: López-Siguero JP, et al.
Published: (2017)